Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Interim report January - September 2024

High level of activity and good orders received   Quarter 3, 2024   · Orders received amounted to SEK 1,437m (1,488), equivalent to a currency neutral decline of 0.3 percent compared with the same period last year. · Net sales amounted to SEK 1,416m (1,574), equivalent to a currency neutral decline of 6.8 percent compared with the same period last year. · Adjusted EBITA was SEK 160.8m (175.4), giving an adjusted EBITA margin of 11.4 percent (11.1). · Operating profit amounted to SEK 129.0m (148.0), corresponding to an operating margin of 9.1 percent (9.4). · Net

SBB starts construction of new care home at Tenstaterrassen in Stockholm

Samhällsbyggnadsbolaget i Norden AB (“SBB”) is starting construction of a new nursing and care home at Tenstaterrassen in Stockholm, with construction scheduled to begin in the fourth quarter of 2024. The home will offer 80 beds spread over 8 wards and 6 floors. With its location next to Järvafältet, residents will have easy access to nature, recreation, and good transport links in the neighbourhood. “We look forward to contributing, together with the tenant Ersta diakoni, to new and much-needed housing for the elderly in Stockholm. Our joint ambition is to create a home-like environment

Q3 2024: Tangible improvement in operations

Important events during the third quarter · Net sales in Q3 amounted to SEK 143.7 m, corresponding to a decrease of 7.9% compared to last year (-5.1% adjusted for currency effects). · The EBITDA margin was 20.1%, corresponding to an increase of 2.0 %-points compared to last year. · Probi successfully implemented a new global ERP system, streamlining operations and enhancing efficiency across key business functions. · A new study suggests that consuming Probi's proprietary probiotic strain HEAL9[®] may serve as a potential therapeutic option for mitigating mild cognitive

YIT receives an order for the first phase of the construction of the Pirkkala-Linnainmaa tramway

YIT Corporation Investor News 22 October 2024 at 9:00 a.m.The Pirkkala-Linnainmaa tramway alliance will enter the implementation phase after the municipalities in the area came to a decision on the construction of the tramway. YIT is involved in the project as an alliance partner as part of a group, where YIT and NRC Group Finland are responsible for the construction and AFRY Finland Oy and Sweco Finland Oy are responsible for the design. The group of companies was selected as a service provider for the development phase of the project in the autumn of 2023. The project was commissioned by

Wallenstam’s interim report Jan–Sep 2024

Hans Wallenstam, CEO, and Susann Linde, CFO and Head of Investor Relations, comment on the report at www.wallenstam.se/filmsandpresentations. The film will be released by 08.30 (CEST) at the latest. An audiocast in English with Susann Linde will take place at 09.00 (CEST) at www.finwire.tv. The presentation is available at www.wallenstam.se/filmsandpresentations before 09.00 (CEST). January 1–September 30, 2024 · The equity/assets ratio amounted to 45 percent (46) and the loan-to-value ratio was 46 percent (46). · Investment in new construction and reconstruction of properties

Ponsse’s Interim Report for 1 January – 30 September 2024

Ponsse Plc Interim report22 October 2024, 9:00 a.m.Ponsse’s Interim Report for 1 January – 30 September 2024 July-September:– Net sales amounted to EUR 169.3 (169.2) million– Operating profit totalled EUR 18.5 (6.5) million, equalling 11.0 (3.9) per cent of net salesJanuary-September:– Net sales amounted to EUR 526.9 (579.0) million– Operating profit totalled EUR 19.1 (33.4) million, equalling 3.6 (5.8) per cent of net sales– Net result was EUR 0.3 (22.4) million– Earnings per share were EUR 0.01 (0.80)– Order books stood at EUR 199.1 (282,3) million at the end of

Continued strong order intake and margin in challenging markets

During the third quarter, Inwido showed once again that the group can grow profitably even if the market conditions are far from optimal. Both order intake and order backlog increased for the second consecutive quarter. The operating EBITA margin increased, even though invoicing decreased slightly compared to the corresponding quarter last year."Although demand in some market segments has started to rise since the spring, and leading macroeconomic indicators have gradually become more positive, several of our business units are challenged by low demand and fierce price pressure, above all

Interim report, January-September 2024

Continued strong order intake in challenging marketsThird quarter 2024 · Net sales amounted to SEK 2,273 million (2,339), down 3 percent. Organic growth amounted to negative 1 percent. · Total order intake increased by 3 percent, while the order backlog increased to SEK 2,640 million (2,428) as of September 30. · Operating EBITA amounted to SEK 304 million (308) and the operating EBITA margin increased to 13.4 percent (13.2). · Earnings per share before and after dilution amounted to SEK 3.23 (3.25) and SEK 3.22 (3.25), respectively. · Net debt amounted to a multiple of 1.2

Boliden Q3 2024: High production, stronger results

“Our mine production during the quarter has been good. Just like last quarter, our Finnish smelters are producing very well.” – Mikael Staffas, President and CEO.Financials · Revenues: SEK 22,193 m (19,396) · Operating profit: SEK 3,165 m (1,912) · Operating profit excl. PIR*: SEK 2,999 m (1,940) · Free cash flow: SEK -495 m (-1,200) · Earnings per share: SEK 8.34 (4.96) *Process Inventory Revaluation Highlights · Operating profit excluding revaluation of process inventory totaled SEK 2,999 m (1,940) · Free cash flow was SEK -495 m (-1,200)  · Improved

Panoro Energy – Dussafu Operations Update

Oslo, 22 October 2024 – Panoro Energy ASA (“Panoro” or the “Company”) is pleased to provide an update on operations at the Dussafu Marin Permit offshore Gabon in which Panoro holds a 17.5 per cent participating interest. John Hamilton, CEO of Panoro, commented: “We are pleased to have safely and successfully delivered the current production drilling campaign at Dussafu, which was expanded to eight wells in order to accommodate fast-track development of the two new discoveries which were announced during May 2024. With five out of the eight wells presently onstream, in addition to the

Growth in all customer segments and low losses

DNB’s profit in the third quarter of 2024 was NOK 12.2 billion. This is NOK 2.1 billion (19.9 per cent) higher than in the third quarter of 2023. The good results are, among other things, due to increased lending volumes in all three of DNB’s customer segments. Growth in business customers Norway was 0.3 per cent, and in large corporates and international customers, it was 4.7 per cent. In personal customers, growth was 0.8 per cent. “There has been a clear shift in customer behaviour through the summer and into the autumn. Competition in the Norwegian bank market remains fierce, and

Interim Report July–September 2024

Strong cash flow and improved earnings in Norway and Finland· Net sales amounted to SEK 6,575 million (6,583) · The order backlog was SEK 16,610 million (16,459) · EBITA decreased by 17 percent to SEK 294 million (352) · The EBITA margin was 4.5 percent (5.4) · Profit after tax was SEK 200 million (251) · Cash flow from operating activities was SEK 193 million (-212) · Net debt amounted to SEK -2,579 million (-3,036) · One acquisition was completed during the quarter, adding annual sales of approximately SEK 27 million · Basic and diluted earnings per share were SEK

Interim Report Jan–Sep 2024

Rental income and the operating surplus improved in comparison with the previous year.  The value changes turned positive during the third quarter. Overall, this meant that earnings before and after tax improved significantly.· Rental income increased to SEK 2,577m (2,539). In an identical property portfolio, income increased with 5 per cent compared with the previous year. · Net operating income increased to SEK 1,924m (1,900). In an identical property portfolio, net operating income increased by 4 per cent. · The surplus ratio was 75 per cent (75). · Contract sales residential

MINIMUM ACCEPTANCE CONDITION SATISFIED FOR THE UNREGULATED RECOMMENDED VOLUNTARY CASH OFFER OF NOK 13 PER SHARE TO THE SHAREHOLDERS OF EVERFUEL A/S

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART, DIRECTLY OR INDIRECTLY, INTO OR WITHIN CANADA, AUSTRALIA, NEW ZEALAND, SOUTH-AFRICA, HONG KONG, JAPAN OR ANY OTHER JURISDICTION IN WHICH THE DISTRIBUTION OR RELEASE WOULD BE UNLAWFUL. OTHER RESTRICTIONS APPLY. 22 October 2024 Reference is made to the unregulated recommended voluntary cash offer to acquire all issued and outstanding shares in Everfuel A/S (the "Company" or "Everfuel") except for shares owned by the Rollover Shareholders (as defined in the offer document dated 2 September 2024 (the "Offer Document")) or

Saab Q3 2024 results: Strong sales growth and cash flow

Saab presents the results for January-September 2024.“We continue to see increasing demand as European nations need to replenish their defence stocks, which will require long-term efforts. This is reflected in our strong order intake in the third quarter. We are growing to meet this increasing demand, for example by investing in capacity, automating our production and building new plants. At the same time, we are delivering strong growth and improving our profitability,” says Micael Johansson, President and CEO, Saab. Key highlights Q3 2024 ·Order bookings increased 41% and

Thule Group moves to Wihlborgs in Dockan in Malmö

The global sports and outdoor company Thule will move its headquarters to Dockan (Dockporten 1) in central Malmö in summer 2025. The lease is for 3,400 square metres and extends for eight years.Thule Group targets discerning consumers who live an active lifestyle, offering them sports and outdoor products such as bike trailers, rooftop tents, cargo carriers and their well-known roof boxes. The company was founded in 1942 in Hillerstorp and has had its head office in Malmö since 2005. The Dockporten 1 office building, with views over the marina and the strait, is located right in the

Skanska signs additional contract to expand hospital in Astoria, Oregon, USA for USD 153M, about SEK 1.6 billion

Skanska has signed an additional contract with Columbia Memorial Hospital for a hospital expansion project in Astoria, Oregon, USA. The contract is worth USD 153M, about SEK 1.6 billion, which will be included in the US order bookings for the fourth quarter of 2024.The project includes a four story 16,900 square meter (182,000-SF) expansion to the existing hospital to include an expanded emergency department, improved operating rooms, larger patient rooms, space for mechanical equipment, among other enhancements. The expansion will allow Columbia Memorial Hospital to provide new services

Strong growth and profits, but continued weak battery outlook

July-September: · Order intake increased +21% (+18% organic) with strong growth in Data Center Technologies (DCT), offset by negative organic development in AirTech as well as FoodTech. In AirTech, the battery sub-segment was weaker in all regions. DCT had a good level of smaller and mid-sized orders in North and Latin America. FoodTech was at a lower level mainly driven by weaker demand in Climate solutions. · Net sales grew +6% (+5% organic). AirTech declined organically, primarily due to the continued weaker battery sub-segment in APAC and Americas. In DCT successful deliveries

Viaplay Group’s Q3 2024 interim report January-September

Continued focus on performance improvements, product relevance and cost control in all areas   Third quarter financial highlights >        Total reported Group net sales of SEK 4,412m (4,536) and total operating income before associated company income (ACI) and items affecting comparability (IAC) of SEK -56m (-321) >        6% organic sales growth for core operations (Nordics, Netherlands and Select), with reported sales of SEK 4,209m (4,206) and operating income before ACI and IAC of SEK -49m (-112) >        Total reported operating income of SEK 2m (-538) including ACI of

Minesto takes part in high-level energy transition conference and exhibition, Enlit Europe 2024, in Milan

Minesto is participating in one of the biggest international energy conferences, Enlit Europe 2024 taking place in Milan. The exhibition and conference, hosting 700+ international best-in-class technologies supporting energy transition, is held at Fiera Milano di Rho in Milan, Italy this year from 22 – 24 October.The presence of Minesto is strong at Enlit Europe, with CEO Dr Martin Edlund delivering presentations at two sessions on innovation, as well as speaking at the high-level panel session ‘Next Generation of Renewables’ on how Minesto’s technology contributes to the global energy

New honorary doctor with interest in higher purpose in finance

Anjan Thakor, Professor of Finance at Washington University, has been appointed Honorary Doctor at the School of Business, Economics and Law at the University of Gothenburg. He has conducted groundbreaking research in banking and finance, contributing to a deeper understanding and knowledge of the efficiency of financial markets. He is also interested in how a company's higher purpose can create profit for both the company and society.Anjan Thakor is based at the Olin School of Business, Washington University in St. Louis , where he is Director

Akiram Therapeutics' drug candidate AKIR001 cleared to start Phase 1 clinical trial

Akiram Therapeutics, a Swedish biotech company specializing in molecular radiation therapy, announces that the Swedish Medical Products Agency has approved the initiation of a Phase 1 clinical trial for its drug candidate [177]Lu-AKIR001. This marks a key milestone in the company’s development of a pioneering cancer treatment aimed at offering new hope for patients with hard-to-treat tumors.Akiram Therapeutics has developed a new type of targeted radioimmunotherapy, [177]Lu-AKIR001. The therapy holds the potential to become a first-in-class treatment in multiple cancer types, including

The Members of Alma Media’s Shareholders’ Nomination Committee have been appointed

Alma Media Corporation Stock exchange release October 22, 2024 at 8.00 a.m. THE MEMBERS OF ALMA MEDIA’S SHAREHOLDERS’ NOMINATION COMMITTEE HAVE BEEN APPOINTED The following were appointed as members of Alma Media’s Nomination Committee: Timo Aukia, Chairman of the Board of Directors, Ilkka Group; Heikki Herlin, Chairman of the Board of Mariatorp Oy; Henrik Ehrnrooth, Chairman of the Board of Otava Oy; and Rami Vehmas, Senior Portfolio Manager, Ilmarinen Mutual Pension Insurance Company. At the constitutive meeting of the Nomination Committee Henrik Ehrnrooth was chosen as the Chairman.

Embla Medical hf: Interim Report Q3 2024

Announcement no. 12/2024 Interim report Q3 2024 22 October 2024 Sveinn Sölvason, President and CEO, comments: “We delivered solid sales in the third quarter amounting to USD 214 million. Organic sales growth was 7% and local currency growth was 11%. The strong momentum we have seen in EMEA throughout 2024 continued driven by strong performance in Prosthetics & Neuro Orthotics and Patient Care. In our Bracing & Supports business growth was more modest for the quarter. As of September 1, 2024, US Medicare has expanded access to advanced bionics for K2 patients. Healthcare

There are no items matching the current filter
There are no more items matching the current filter
Back to top